Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
about
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansIn vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virusClinical, cellular, and molecular factors that contribute to antifungal drug resistance.Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.Population structure and properties of Candida albicans, as determined by multilocus sequence typing.Antifungal drug resistance.Resistance of Candida species to fluconazoleCorrelation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.Azole antifungal agents: emphasis on new triazoles.Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoFluconazole resistance in Candida glabrataCorrelation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Rapid susceptibility testing of fungi by flow cytometry using vital staining.Antifungals: need to search for a new molecular targetOral yeast infections in immunocompromised and seriously diseased patients.Otitic candidiasis in children: an evaluation of the problem and effectiveness of ketoconazole in 10 patients.Chronic mucocutaneous candidosis.Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.Anti-Candida drugs--the biochemical basis for their activity.Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacyComparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.Characterization of an azole-resistant Candida glabrata isolate.Antifungal susceptibility testingOptions for the management of mucosal candidiasis in patients with AIDS and HIV infection.Ketoconazole: an orally effective antifungal agent. Mechanism of action, pharmacology, clinical efficacy and adverse effects.
P2860
Q24550731-DDA519CC-0F7A-4754-9F4B-8382841F63D6Q28369094-65F85820-EC4D-4983-88A1-CF0719C934FCQ33721804-DAD88924-D6B7-4163-9272-73E639163074Q33894467-A624DC90-6D7A-4BF2-AAA9-9E8807417047Q33981896-35DAE564-B050-47DA-8C8A-2FBA99C877B3Q34143749-D4AE5F6E-63CB-48A6-B6C3-7E5A3556A6BFQ35040008-2EE8735C-A2F9-4FCD-8490-7177BAD15EBBQ35110522-1A5F1D69-1C31-4D77-848E-E8198347A897Q35122459-A354077D-0F77-48C3-9300-C58CB6BF27D9Q35287663-FAFC0E75-F3EA-4B94-908C-524239386E6CQ35652874-7B634B31-31AF-499D-B808-FCC9454FD349Q35819599-42A5286E-B0C7-44B2-B328-AECA69725E18Q35900199-347E33BC-E9E6-4C4A-87FD-4B4D89EFCC7AQ36528018-47991774-9FD2-4747-B076-BB3899FFA2ECQ36542368-57385D7B-85A2-4FCF-AF22-C7C204238D74Q37666705-6E82D8A4-9EE1-44BF-B684-AEA239310680Q37911956-BD44A09F-00B3-4EB5-BBEF-5720C94A9E77Q38090363-BB848C31-41AF-4C15-9F7B-5D4EBFDCC3D0Q39558256-3392F337-63E2-44A3-AEB5-E899AFAD58EEQ39685100-9036A38B-BEBF-47CD-A91B-312B9281CCC8Q39685115-16BB2823-E158-4DBC-AD14-7C91EF5AE48BQ39820104-DC6690B2-E350-4D6E-973E-69E92A771E69Q39833078-3B5FA1E6-E25B-4547-9D60-49021DA58FDFQ39851052-BF5E0E26-6B8B-4705-8275-0C02433EE274Q40088759-EDB3B4E9-7A5A-4120-B35D-38225C8D4F12Q40795131-C3E2A3A9-7689-44C6-8FAC-E18C599A1230Q40827662-A69DE383-DB3E-4BE1-94BE-655EFBBF21F5Q44611755-8B0877F8-E82B-4013-8647-341C5F71816B
P2860
Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Long-term therapy of chronic m ...... ence with twenty-one patients.
@en
Long-term therapy of chronic m ...... ence with twenty-one patients.
@nl
type
label
Long-term therapy of chronic m ...... ence with twenty-one patients.
@en
Long-term therapy of chronic m ...... ence with twenty-one patients.
@nl
prefLabel
Long-term therapy of chronic m ...... ence with twenty-one patients.
@en
Long-term therapy of chronic m ...... ence with twenty-one patients.
@nl
P1476
Long-term therapy of chronic m ...... ence with twenty-one patients.
@en
P2093
C H Kirkpatrick
P356
10.1016/0002-9343(83)90511-9
P407
P50
P577
1983-01-01T00:00:00Z